Evigrade
Major

Iopromide × Ketorolac

X-ray contrast media. Watersoluble nephrotropic low-osmolar iodinated agents×Non-steroidal anti-inflammatory drugs (NSAIDs)

Mechanism

Additive nephrotoxicity. Ketorolac (NSAID) suppresses prostaglandin-dependent renal blood flow; iodinated contrast (iopromide) adds osmotic load. High risk of acute kidney injury.

Symptoms

Reduced urine output, rising creatinine, proteinuria. Severe cases include oliguria and need for haemodialysis. Symptoms appear 1–3 days after contrast.

Management

Stop ketorolac 48 hours before planned contrast and resume 48 hours after with stable renal function. Alternative analgesics: paracetamol, metamizole, or a short opioid course. Provide contrast nephroprotection with adequate saline hydration.

Sources

All interactions